124 related articles for article (PubMed ID: 32755689)
1. Influence of residual solvents on the physical properties of transdermal drug delivery systems.
Mazumder S; Shakleya D; Mattson S; Ashraf M; Faustino P; Pavurala N
Int J Pharm; 2020 Oct; 588():119713. PubMed ID: 32755689
[TBL] [Abstract][Full Text] [Related]
2. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
Mohamed LA; Kamal N; Elfakhri KH; Willett D; Wokovich A; Strasinger C; Cruz CN; Raney SG; Ashraf M; Zidan AS
Int J Pharm; 2020 Mar; 578():119132. PubMed ID: 32057892
[TBL] [Abstract][Full Text] [Related]
3. Impact of Different Mixing Methods on the Performance of Suspension-Based Transdermal Delivery Systems.
Bhattaccharjee SA; Kale M; Le N; Banga AK
AAPS PharmSciTech; 2021 May; 22(4):150. PubMed ID: 33973096
[TBL] [Abstract][Full Text] [Related]
4. Adhesive properties: a critical issue in transdermal patch development.
Cilurzo F; Gennari CG; Minghetti P
Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
[TBL] [Abstract][Full Text] [Related]
5. Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance.
Ho KY; Dodou K
Int J Pharm; 2007 Mar; 333(1-2):24-33. PubMed ID: 17049768
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
Vora D; Banga AK
Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Adhesive Properties of Transdermal Patches Distributing in Japan-Tack and Peel Strength].
Miyazaki T; Kanno H; Aso Y; Goda Y
Yakugaku Zasshi; 2018 Nov; 138(11):1425-1433. PubMed ID: 30146539
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into the effect of drug content on adhesive properties of transdermal patch containing lidocaine.
Wang M; Zhang Y; Li M; Zhao N; Luo Z
Eur J Pharm Sci; 2023 May; 184():106419. PubMed ID: 36878407
[TBL] [Abstract][Full Text] [Related]
10. Statistical Considerations in Assessing In Vivo Adhesion with Transdermal and Topical Delivery Systems for New Drug Applications.
Wang C; Strasinger C; Shen M; Tsong Y
AAPS J; 2020 Oct; 22(6):137. PubMed ID: 33099695
[TBL] [Abstract][Full Text] [Related]
11. Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
Drug Dev Ind Pharm; 2011 Oct; 37(10):1217-24. PubMed ID: 21438703
[TBL] [Abstract][Full Text] [Related]
12. On the characterization of medicated plasters containing NSAIDs according to novel indications of USP and EMA: adhesive property and in vitro skin permeation studies.
Cilurzo F; Gennari CG; Selmin F; Franzé S; Musazzi UM; Minghetti P
Drug Dev Ind Pharm; 2015 Feb; 41(2):183-9. PubMed ID: 24164486
[TBL] [Abstract][Full Text] [Related]
13. Mixture design approach for early stage formulation development of a transdermal delivery system.
Michaelis M; Leopold CS
Drug Dev Ind Pharm; 2015; 41(9):1532-40. PubMed ID: 25308745
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in silicones for topical and transdermal drug delivery.
Aliyar H; Schalau G
Ther Deliv; 2015 Jul; 6(7):827-39. PubMed ID: 26228774
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.
Ganti SS; Bhattaccharjee SA; Murnane KS; Blough BE; Banga AK
Int J Pharm; 2018 Oct; 550(1-2):71-78. PubMed ID: 30125654
[TBL] [Abstract][Full Text] [Related]
16. Spray-on transdermal drug delivery systems.
Ibrahim SA
Expert Opin Drug Deliv; 2015 Feb; 12(2):195-205. PubMed ID: 25227233
[TBL] [Abstract][Full Text] [Related]
17. Effect of residual solvent in polymer adhesive matrix on release and skin permeation of scopolamine.
Anders K; Lee G
Int J Pharm; 2015 Aug; 491(1-2):42-8. PubMed ID: 26068196
[TBL] [Abstract][Full Text] [Related]
18. Swelling of medical grade silicones in liquids and calculation of their cross-link densities.
Mahomed A; Hukins DW; Kukureka SN
Med Eng Phys; 2010 May; 32(4):298-303. PubMed ID: 20080429
[TBL] [Abstract][Full Text] [Related]
19. Replacing xylene with n-heptane for paraffin embedding.
Stockert JC; López-Arias B; Del Castillo P; Romero A; Blázquez-Castro A
Biotech Histochem; 2012 Oct; 87(7):464-7. PubMed ID: 22853037
[TBL] [Abstract][Full Text] [Related]
20. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
